Test Summary Sheet for:

Purpose
Overexposure/Poisoning Determination
Method(s)
Gas Chromatography/Mass Spectrometry (GC/MS)
Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES)
Suggested CPT Code(s)
82375
82375
83540
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Carbon Monoxide Gas Chromatography/Mass Spectrometry (GC/MS) mcg/mL 110 Biological Marker (Exposure)
2 Iron Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) mg/dL 4.0 Metal/Element
3 Carboxyhemoglobin COHb Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) %Saturation Biological Marker (Exposure)

Specimen Type
Blood
Requested Volume
5 mL
Minimum Volume
2.4 mL
Special Handling
Clotted Blood specimens are not acceptable.
Submit in container with a non-Heparin based anticoagulant. Tubes containing Heparin based anticoagulants are not acceptable.
Specimen Container
Lavender top tube (EDTA), Royal Blue top tube (Trace metal-free; EDTA)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Light Green top tube (Lithium Heparin). Tan top tube - glass (Sodium Heparin). Royal Blue top tube (Trace metal-free; Sodium Heparin). Green top tube (Sodium Heparin).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Undetermined
Refrigerated: Undetermined
Frozen (-20 °C): Undetermined
1 Carbon Monoxide Gas Chromatography/Mass Spectrometry (GC/MS) mcg/mL 110 Biological Marker (Exposure)
2 Iron Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) mg/dL 4.0 Metal/Element
3 Carboxyhemoglobin COHb Inductively Coupled Plasma/Optical Emission Spectrometry (ICP/OES) %Saturation Biological Marker (Exposure)

Interface Map

LOINC® Information

The CPT Codes provided in this document are based on AMA Guidelines and are for informational purposes only. NMS Labs Does not assume responsibility for billing errors due to Reliance on the CPT Codes listed in this document.

*The information contained in this document represents database configurations, as they will appear on the effective date listed above.